Intravitreal Bevacizumab Proves Effective For Choroidal Neovascularization
Thursday, May 15th, 2008Researchers at the University of Bonn and Hospital Saarbrücken find Intravitreal bevacizumab a solution to choroidal neovascularization patients to secondary pseudoxanthoma elasticum. Robert P. Finger and his colleagues have tested the study to 15 patients. All these patients had active CNV secondary on pseudoxanthoma elasticum.
